help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mihály, E.
Right arrow Articles by Lechan, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mihály, E.
Right arrow Articles by Lechan, R. M.
The Journal of Clinical Endocrinology & Metabolism Vol. 85, No. 7 2596-2603
Copyright © 2000 by The Endocrine Society


Original Studies

Hypophysiotropic Thyrotropin-Releasing Hormone-Synthesizing Neurons in the Human Hypothalamus Are Innervated by Neuropeptide Y, Agouti-Related Protein, and {alpha}-Melanocyte-Stimulating Hormone1

Emese Mihály, Csaba Fekete, Jeffrey B. Tatro, Zsolt Liposits, Ed G. Stopa and Ronald M. Lechan

Tupper Research Institute and Department of Medicine, Division of Endocrinology, Diabetes, Metabolism, and Molecular Medicine, New England Medical Center (E.M., C.F., J.B.T., R.M.L.), Boston, Massachusetts 02111; Department of Neurobiology, Institute of Experimental Medicine, Hungarian Academy of Sciences (C.F., Z.L.), 1083 Budapest, Hungary; Department of Pathology (Neuropathology Division), Brown University School of Medicine/Rhode Island Hospital (E.G.S.), Providence, Rhode Island 02903; and Department of Neuroscience, Tufts University School of Medicine (R.M.L.), Boston, Massachusetts 02111

Address all correspondence and requests for reprints to: Ronald M. Lechan, M.D., Ph.D., Division of Endocrinology, Box No. 268, New England Medical Center, 750 Washington Street, Boston, Massachusetts 02111. E-mail: rlechan{at}lifespan.org


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
We recently demonstrated that three arcuate nucleus-derived peptides, neuropeptide Y (NPY), agouti-related protein (AGRP), and {alpha}MSH, are contained in axon terminals that heavily innervate hypophysiotropic TRH neurons in the rat brain and may contribute to the altered set-point of the hypothalamo-pituitary-thyroid axis during fasting. To determine whether a similar regulatory system exists in human brain, we performed a series of immunohistochemical studies using antisera against NPY, AGRP, {alpha}MSH, and TRH in adult hypothalami obtained within 15 h of death. Numerous small to medium-sized, fusiform and multipolar NPY-, AGRP-, and {alpha}MSH-immunoreactive (-IR) cells were widely distributed throughout the rostro-caudal extent of the infundibular (arcuate) nucleus. A similar distribution pattern was found for NPY- and AGRP-IR neurons in the arcuate nucleus, whereas {alpha}MSH-IR cells appeared to form a separate cell population. By double labeling fluorescent immunohistochemistry, 82% of NPY neurons cocontained AGRP, and 87% of AGRP neurons coexpressed NPY. No colocalization was found between {alpha}MSH- and AGRP-IR neurons. NPY-, AGRP-, and {alpha}MSH-containing axons densely innervated the hypothalamic paraventricular nucleus and were found in close juxtaposition to TRH-synthesizing cell bodies and dendrites. These studies demonstrate that in man, the NPY-, AGRP-, and {alpha}MSH-IR neuronal systems in the infundibular and paraventricular nuclei are highly reminiscent of that observed in the rat and may similarly be involved in regulating the hypothalamo-pituitary-thyroid axis in the human brain.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
THE HYPOTHALAMIC arcuate nucleus is well established as a major target for the central actions of leptin to regulate energy homeostasis in response to fasted or fed states (1, 2). This region of the brain contains a high concentration of leptin receptors expressed in several populations of neurons, including neuropeptide Y (NPY)-, agouti-related protein (AGRP)-, and POMC-containing neurons (3, 4, 5, 6, 7, 8, 9), that are involved in the regulation of appetite, reproductive function, autonomic regulation, and thermogenesis (10, 11, 12, 13). Two of these peptides, NPY and AGRP, are coexpressed in the medial part of the arcuate nucleus in the rat, whereas POMC-derived peptides originate from arcuate neurons located more laterally, constituting a clearly distinct cell group from AGRP-expressing neurons (14). Recent studies from our laboratory have demonstrated that both NPY- and AGRP- containing neurons located in the arcuate nucleus project heavily to the hypothalamic paraventricular nucleus (PVN) in the arcuato-paraventricular pathway and establish numerous synapses with TRH-producing neurons (15, 16). As both AGRP and NPY messenger ribonucleic acid (mRNA) are markedly increased in the arcuate nucleus during fasting (9, 17), simultaneous with a reduction in pro-TRH mRNA in the PVN, we proposed that AGRP and NPY may mediate the inhibitory effect of fasting on pro-TRH gene expression and contribute to the reduction in thyroid hormone levels in fasting animals (18). Conversely, POMC mRNA is reduced by fasting in arcuate nucleus neurons and is increased by the systemic administration of leptin (19, 20). As {alpha}MSH, a cleavage product of POMC, is also contained in axon terminals that innervate TRH neurons in the rat PVN and has a stimulatory effect on pro-TRH gene expression when injected into the cerebrospinal fluid (21), we have further proposed that {alpha}MSH may be responsible for the restoration of pro-TRH mRNA in PVN neurons of fasting animals treated with leptin.

To determine whether regulatory control of hypophysiotropic TRH neurons in man are similar to that observed in the rat, we performed a series of immunohistochemical studies on adult human hypothalami using specific antisera to NPY, AGRP, {alpha}MSH, and TRH, looking primarily at the infundibular nucleus, the human equivalent of the rat arcuate nucleus, and the PVN. A preliminary report of these findings has been presented in abstract form (22).


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Tissue preparation

Hypothalami from three adults with no history of neurological or endocrinological impairment were obtained at routine autopsies (Table 1Go). Tissue samples were taken within 15 h of death. The diencephalic blocks were fixed in 4% paraformaldehyde for 48–72 h at 4 C, then cryoprotected in 30% sucrose and frozen on dry ice. Serial 30-µm thick coronal sections were cut parallel to the lamina terminalis on a cryostat (2800 Frigocut-E, Reichert-Jung, Vienna, Austria) and stored in phosphate-buffered saline (PBS) containing 0.2% sodium azide at 4 C until immunohistochemical or immunofluorescent processing.


View this table:
[in this window]
[in a new window]
 
Table 1. Summary of human cases

 
Immunohistochemical analysis

Single and double label immunohistochemistry was performed at the light microscopic level to establish the distribution of neuronal perikarya and fibers containing NPY, AGRP, {alpha}MSH, and TRH in the hypothalamic infundibular and paraventricular nucleus and the possible relationships among them. Hypothalamic sections were pretreated with 3% hydrogen peroxide and 0.45% Triton X-100 (Sigma, St. Louis, MO) in PBS for 15 min to reduce endogenous peroxidase activity and improve antibody penetration, respectively, and then were immersed in 10% normal horse serum in PBS for 30 min to abolish nonspecific antibody binding. Tissue sections were then incubated with one of the following primary antibodies: rabbit anti-NPY (1:50,000; Peninsula Laboratories, Inc., Belmont, CA), rabbit anti-AGRP (1:20,000; Phoenix Pharmaceuticals, Inc., Mountain View, CA), or sheep anti-{alpha}MSH (1:150,000; raised in our laboratory) (23), each for 48 h at 4 C. After washing in PBS, sections were incubated in biotinylated donkey antirabbit IgG or biotinylated donkey antisheep IgG (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA) at 1:500, depending on the first antibody, for 2 h at room temperature. Both primary and secondary antisera were diluted in 2.5% normal horse serum and 0.2% sodium azide containing PBS. After further rinsing in PBS, the sections were immersed in avidin-biotin complex (1:100; Vector Elite Kit, Vector Laboratories, Inc., Burlingame, CA) for 2 h, rinsed, and then developed in 0.05% diaminobenzidene-0.15% nickel ammonium sulfate-0.005% H2O2 in 0.05 mol/L Tris buffer, pH 7.6, for approximately 5 min. The reaction was stopped by immersion of tissue sections in 0.05 mol/L Tris buffer, washed in 2% sodium acetate (pH 7.2), and then silver intensified (24) to obtain a black reaction product. After additional washes in PBS, the tissue sections for double label immunohistochemistry were transferred to rabbit anti-TRH antiserum (25) (diluted 1:4,000) for 2 days at 4 C. Biotinylated donkey antirabbit IgG (The Jackson Laboratory, Bar Harbor, ME) was used as the second antibody (diluted 1:500), and after further washes and incubation in avidin-biotin complex Elite reagent (1:100; Vector Laboratories, Inc.), the tissue was reacted with 0.025% diaminobenzidene-0.0036% H2O2 in PBS to yield a contrasting brown reaction product.

The sections were mounted onto SuperFrost slides (Fisher Scientific, Pittsburgh, PA), air-dried, dehydrated in an ascending series of alcohol, cleared in Histosol (National Diagnostics, Atlanta, GA), and then coverslipped with DPX (Fluta, Ronkonkoma, NY). Some of the double labeled sections were embedded in Epon-resin for preparation of semithin sections. The resin was polymerized at 56 C for 2 days, then the region of interest was cut out with a razor blade, glued onto a Durcupan (Fluta) block, and sectioned on an MT 6000 ultramicrotome (RML, Inc., Tucson, AZ).

The distribution of NPY, AGRP, and {alpha}MSH perikarya in the arcuate nucleus and the innervation of the PVN by these systems were analyzed by light microscopic examination using a Carl Zeiss Axioskop 2 epifluorescent microscope (New York, NY). The percentage of TRH neurons receiving contacts on their perikarya and first order dendrites by immunoreactive axon terminals of each peptide, respectively, was determined. The data are presented as the mean ± SEM.

The specificity of immunostaining with NPY, {alpha}MSH, and TRH antisera was demonstrated by the loss of immunoreactivity after preabsorption of the diluted antisera with an excess of synthetic NPY (10-5 mol/L), {alpha}MSH (10-5 mol/L), and TRH (10-3 mol/L) peptides, respectively. The specificity of the AGRP antiserum has been previously reported (15). In addition, no specific staining could be detected by omission of each primary or secondary antiserum.

Immunofluorescence

To determine whether NPY, AGRP, and {alpha}MSH are expressed in the same neurons, a double labeling immunofluorescence method was used. Tissue sections were immersed in 1% sodium acetate for 1 min, then treated in graded solutions of acetone (50%, 70%, 90%, 100%, and 90%) for 5 min each, washed in 70% ethanol, and treated with 0.3% Sudan black in 70% ethanol for 30 min to reduce autofluorescence (26). After differentiation in 70% ethanol, sections were washed in PBS, pretreated with 10% normal horse serum in PBS, and incubated in one of the following mixtures: 1) rabbit anti-AGRP (1:3000; Phoenix Pharmaceuticals, Inc.) and sheep anti-NPY (1:1000; Chemicon International, Inc., Temecula, CA), 2) rabbit anti-AGRP (1:3000) and sheep anti-{alpha}MSH (1:5000), 3) rabbit anti-NPY (1:5000; Peninsula Laboratories, Inc.) and sheep anti-{alpha}MSH (1:5000), respectively, for 4 days at 4 C. After washes in PBS, tissues were immersed in a mixture containing biotinylated donkey antirabbit IgG (1:500; The Jackson Laboratory) and Texas Red-conjugated antisheep IgG (1:40; The Jackson Laboratory) for 1 day at 4 C. Sections were washed in PBS and further incubated in fluorescein isothiocyanate-avidin D cell-sorting grade (Vector Laboratories, Inc.; diluted at 1:250) for 1 day at 4 C. After washes, sections were mounted on SuperFrost slides (Fisher Scientific, Pittsburgh, PA), coverslipped with Vectashield (Vector Laboratories, Inc.), and analyzed under a Carl Zeiss Axioskop 2 epifluorescent microscope using the following filter sets: Texas Red (excitation, 540–590 nm; bandpass, 595 nm; emission, 600–660) and fluorescein isothiocyanate (excitation, 460–500 nm; bandpass, 505 nm; emission, 510–560 nm). Thus, AGRP appeared green, and NPY or {alpha}MSH, respectively, appeared red by fluorescent microscopy in the AGRP and NPY or {alpha}MSH colocalization study, whereas NPY appeared green, and {alpha}MSH appeared red when colocalization of NPY with {alpha}MSH was studied. Images were captured with a Spot digital camera (Diagnostic Instruments, Inc., Sterling Heights, MI), the same field was double exposed by switching the filter sets for each fluorochrome, and the images were superimposed using Adobe Photoshop 5.0 and a Macintosh G3 computer (Apple Computer, Inc., Cupertino, CA). Only the brightness and contrast were adjusted in the final digitized image.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Distribution of NPY-, AGRP-, and {alpha}MSH-immunoreactive (IR) neurons in the hypothalamic infundibular nucleus

NPY- and AGRP-IR neurons were present throughout the rostro-caudal extent of the infundibular nucleus embedded in a dense NPY- or AGRP-IR fiber network, respectively (Fig. 1Go, A–F). Occasional neurons extended further laterally in the neuropil of the hypothalamus. Single label immunohistochemistry revealed that the size, shape and distribution of NPY- and AGRP-IR neurons were similar; both were small to medium sized and fusiform or multipolar in shape (Fig. 1Go, A–F). NPY- and AGRP-IR perikarya were observed mainly in the medial part of the infundibular nucleus at the rostral level of the nucleus (Fig. 1Go, A and D). At the midlevel of the infundibular nucleus, they organized into two distinct groups, one in the medial portion and a second in the lateral portion of the infundibular nucleus, with a relative paucity of immunoreactive cells in the central part of the nucleus (Fig. 1Go, B and E), whereas in the caudal regions, NPY- and AGRP-producing cells showed higher concentrations laterally (Fig. 1Go, C and F).



View larger version (145K):
[in this window]
[in a new window]
 
Figure 1. Brightfield photomicrographs (rostral-caudal) demonstrating the distribution of NPY-IR (A–C), AGRP-IR (D–F), and {alpha}MSH-IR (G–I) neurons in the human infundibular nucleus. At the anterior level of the infundibular nucleus NPY-IR (A) and AGRP-IR (D) neurons are found in the medial part of the nucleus, whereas at the midlevel (B and E) they are located in the medial and lateral parts, with a relative paucity of the immunoreactive cells and fibers in the central part of the nucleus (asterisk). At the caudal level NPY-containing (C) and AGRP-containing (F) cells are observed mainly laterally. {alpha}MSH-IR neurons are dispersed throughout the infundibular nucleus, but are concentrated mainly laterally at the anterior (G) and caudal (I) levels of the nucleus. At the midlevel (H), however, {alpha}MSH-IR cells showed a similar distribution as NPY- and AGRP-IR cells. The lack of the immunostaining in the central part of the arcuate nucleus was also observed (asterisk). Scale bar, 200 µm. The insets in C, F, and I show NPY-, AGRP-, and {alpha}MSH-IR perikarya, respectively. The majority of NPY- and AGRP-IR perikarya are fusiform, although multipolar neurons also can be seen. In contrast, {alpha}MSH-IR neurons are multipolar. Scale bar, 10 µm.

 
{alpha}MSH-IR perikarya were also dispersed throughout the rostro-caudal extent of the infundibular nucleus, but were concentrated in the lateral portions of the nucleus at the anterior and caudal levels (Fig. 1Go, G and I). At the midlevel of the nucleus, however, the distribution pattern of {alpha}MSH-positive neurons was similar to that seen for NPY- and AGRP-IR perikarya; {alpha}MSH-containing neurons were located in medial and lateral portions of nucleus, with the lack of immunostaining in the central part (Fig. 1HGo). Morphologically, these cells were distinct from NPY- and AGRP- containing cells, being medium sized and multipolar.

Colocalization of AGRP, NPY, and {alpha}MSH immunoreactivity in infundibular nucleus neurons

By double labeling immunofluorescence, AGRP and NPY immunoreactivity appeared to be cocontained in the majority of the same infundibular nucleus neurons (Fig. 2Go, A and B). Cell counts throughout the rostro-caudal extent of the infundibular nucleus revealed that approximately 86.5 ± 1.3% of AGRP neurons cocontained NPY. Colocalization was particularly apparent at the anterior level of the nucleus, where nearly 100% of AGRP-IR neurons were double labeled. The majority of single labeled AGRP-IR neurons were located at the midlevel of the arcuate nucleus in the medial portion. Conversely, 81.8 ± 6.4% of NPY-synthesizing perikarya in the infundibular nucleus contained AGRP; however, the majority of colocalized neurons were located at the mid- and caudal levels of the nucleus. No colocalization of AGRP or NPY with {alpha}MSH was seen in any infundibular nucleus neuron (Fig. 2Go, C and D).



View larger version (85K):
[in this window]
[in a new window]
 
Figure 2. Anatomical relationship between NPY-, AGRP-, and {alpha}MSH-IR neurons in the infundibular nucleus (A–C). A and B, Both NPY (A) and AGRP (B) immunoreactivity localize in the same arcuate nucleus neurons and fibers using an immunofluorescence technique. In contrast, no colocalization between {alpha}MSH-IR (C) and AGRP-IR (D) cells is seen in photomicrographs taken from the identical field (D and C). Scale bar, 100 µm in A and B; 50 µm in C and D.

 
Distribution of NPY-, AGRP-, and {alpha}MSH-containing fibers in the PVN

The PVN contained a high density of strongly stained NPY-IR fibers throughout the nucleus (Fig. 3Go, A–C). The thin varicose fibers formed a rich network within the nucleus, and some pericellular baskets were also seen. Both parvo- and magnocellular parts were innervated. Occasionally, small NPY-positive perikarya were identified in both parvo- and magnocellular subdivisions. AGRP-IR beaded fibers were also dispersed throughout the PVN, although their distribution varied somewhat from that observed for NPY- containing fibers. The periventricular part of the anterior PVN exhibited a higher concentration of immunoreactive fibers, whereas the mid- and caudal PVN received uniform innervation (Fig. 3Go, D–F). A medium density of {alpha}MSH-IR fibers was found throughout the PVN. The lateral region of the nucleus exhibited the densest pattern of labeled, large varicose fibers (Fig. 3Go, H–J). Immunoreactivity for all three peptides, respectively, was identified just lateral to the PVN and above the fornix in the dorsal hypothalamic area and appeared to enter the PVN.



View larger version (152K):
[in this window]
[in a new window]
 
Figure 3. Low magnification photomicrographs show the distribution of NPY-IR (A–C), AGRP-IR (D–F), and {alpha}MSH-IR (G–I) fibers in the human PVN. A rich NPY-IR fiber network is seen in the anterior (A), mid (B), and caudal (C) levels of the PVN. Scattered NPY-positive cells are also observed. D–F, Rostro-caudal distribution of AGRP-IR fibers in the PVN. Note the high density of axons in the periventricular part of the anterior PVN (arrows). G–I, Thick, beaded {alpha}MSH-IR fibers were present throughout the PVN. The lateral part of the nucleus received the greatest {alpha}MSH-IR innervation. Scale bar, 200 µm.

 
Distribution of TRH-IR perikarya in the PVN and innervation by NPY-, AGRP-, and {alpha}MSH-containing fibers

TRH-positive cells were observed throughout the PVN, but were mostly concentrated in the medial region of the midlevel of the nucleus (Fig. 4Go, A–C). The majority of the cells were small, multipolar, and round in shape, but some scattered large neurons were also seen. NPY axon varicosities were found in close juxtaposition to 77.9 ± 3.2% of TRH-containing perikarya and dendrites (Fig. 5AGo). This close relationship was particularly apparent in the anterior and midlevel of the nucleus. AGRP-IR terminals were closely apposed to approximately 60.6 ± 3.1% of TRH-synthesizing neurons, uniformly throughout the nucleus (Fig. 5BGo). In some instances the AGRP-IR innervation was so intense that varicosities formed fiber baskets around the TRH neurons, outlining the cell surface. {alpha}MSH-positive fibers were closely apposed to approximately 58.5 ± 10.5% of TRH-IR perikarya (Fig. 5CGo), making contacts with both dendritic processes and soma of TRH neurons. Close appositions of NPY-, AGRP-, and {alpha}MSH-IR axon varicosities to TRH-synthesizing perikarya were also found in semithin sections (Fig. 5Go, D–F).



View larger version (71K):
[in this window]
[in a new window]
 
Figure 4. Three rostro-caudal sections show the distribution of TRH-IR neurons in the anterior (A), mid (B), and caudal (C) levels of the PVN. Note the high concentration of the immunoreactive cells in the midlevel of the nucleus. Scale bar, 200 µm.

 


View larger version (89K):
[in this window]
[in a new window]
 
Figure 5. The association between axon terminals containing NPY, AGRP, and {alpha}MSH immunoreactivity (arrows) with TRH-positive perikarya in the PVN is shown in A–F. A multipolar TRH-IR neuron is heavily contacted by NPY-IR axon terminals (A). AGRP-IR axon varicosities establish numerous axo-somatic and axo-dendritic connections with a TRH-positive cell (B). {alpha}MSH-IR axon varicosities densely cover the dendrite of a TRH-containing neuron (C). Similar associations between NPY-, AGRP-, and {alpha}MSH-IR axon terminals and TRH-containing cells are shown in 1-µm thick sections in D–F. Scale bar, 20 µm.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
These studies indicate that the anatomical organization of hypophysiotropic TRH neurons in the PVN is remarkably similar to that described in the rodent brain with respect to its innervation by NPY-, AGRP-, and {alpha}MSH-containing axon terminals (15, 16, 21, 27). Since the major origin of the innervation of TRH neurons in the PVN by all three of the above peptides in the rat is the arcuate nucleus (15, 16, 21), we first examined the relative distributions of neurons containing NPY, AGRP, and {alpha}MSH in the human infundibular nucleus using highly specific antiserum and single and double labeling immunocytochemistry. Both NPY- and AGRP-IR neurons were identified in the hypothalamic infundibular nucleus, contained in the perikarya of small and medium-sized neurons throughout the medial part of the nucleus, but also in basolateral portions of the nucleus in mid- and caudal levels. Double labeling immunofluorescent studies demonstrated that approximately 82% of NPY-containing neurons also contained AGRP, whereas 87% of AGRP-containing neurons coexpressed NPY, indicating that, as in the rat brain (14), these two peptides are substantially colocalized in the same infundibular nucleus neurons. In contrast, {alpha}MSH immunostaining was located in a morphologically distinct group of neurons and was located predominantly in the lateral regions of the infundibular nucleus. It was not surprising, therefore, that, similar to other animal species (14), double labeling immunofluorescence in the human brain demonstrated that {alpha}MSH-containing neurons and NPY-/AGRP-containing neurons form separate cell populations in the infundibular nucleus.

Within the PVN, however, all three peptides were present in axon terminals that heavily inundated the nucleus. The substantial overlap between AGRP- and NPY-containing axons in the PVN is consistent with these two peptides arising from the same infundibular nucleus neurons. The NPY innervation of the PVN, however, was more extensive than the AGRP innervation. Similarly, whereas both NPY- and AGRP-IR axon varicosities were found in close juxtaposition to the majority of TRH-containing cell bodies in the PVN, in some instances outlining the entire surface and first order dendrites with numerous contacts, a greater percentage of TRH neurons was contacted by NPY- than AGRP-containing axons. If AGRP in the human brain originates exclusively from the arcuate nucleus, as in the rat and mouse (15, 28), one might presume that the more extensive NPY innervation of TRH neurons suggests a more widespread origin of NPY-containing axons from neuronal populations in the regions of the brain in addition to the arcuate nucleus. Potential sources of NPY from regions that have known projection pathways to the PVN in the rat and human include the lateral and dorsomedial medulla, where NPY colocalizes with catecholamines (29, 30, 31), the bed nucleus of the stria terminalis (32), and the lateral geniculate (33).

{alpha}MSH-containing axons also heavily inundated TRH neurons in the PVN, outlining soma and dendrites of approximately 58% of the TRH neurons. As both {alpha}MSH- and AGRP-containing axons innervate the majority of TRH neurons, the likelihood that at least a subpopulation of TRH neurons are innervated by both peptides would appear strong. The potential significance of dual innervation by AGRP and {alpha}MSH is implicit in the demonstration that these two peptides antagonize each other at the same receptor. Thus, in mouse skin, the homologue of AGRP, agouti, and {alpha}MSH both bind to the melanocortin-1 receptor (MC-1R) to regulate skin color (34). Similarly, in the brain, AGRP competes with {alpha}MSH for binding to the MC-4R, inhibiting the anorectic effects of {alpha}MSH and inducing feeding behavior (10, 35). Thus, the dual innervation of TRH neurons in the PVN of the human brain by AGRP- and {alpha}MSH-containing axons would suggest opposing actions of these two peptides on the regulation of hypophysiotropic TRH.

AGRP/NPY and {alpha}MSH mRNA levels are affected by nutritional status. Thus, during starvation, when circulating leptin levels fall, arcuate nucleus-derived AGRP and NPY mRNA levels increase, POMC mRNA decreases (17, 19, 20, 36, 37, 38, 39), and pro-TRH gene expression in hypophysiotropic neurons decreases (40, 41, 42). These changes are associated with low or inappropriately normal circulating TSH and reduction of thyroid hormone levels, characteristic of the nonthyroidal illness syndrome (41, 43). Recent studies from our laboratories (40) have demonstrated that the systemic administration of leptin to fasting rats, which inhibits AGRP and NPY mRNA and stimulates {alpha}MSH gene expression (9, 17, 19, 20), restores circulating thyroid hormone levels to normal. In addition, infusion of {alpha}MSH to fasting rats prevents the fasting-induced suppression of pro-TRH mRNA in the PVN (21). We presume, therefore, that AGRP and NPY may exert inhibitory effects on TRH neurons, whereas the effect of {alpha}MSH may be stimulatory. However, mice with deletion in NPY gene show a similar reduction in T4 levels during fasting (44), raising the possibility that AGRP may have a compensatory role in these animals or that additional mechanisms are called into play.

On the basis of the above observations, we conclude that in the human brain, NPY, AGRP, and {alpha}MSH are anatomically situated to exert regulatory control over hypophysiotropic TRH neurons in the PVN. We propose, therefore, that the human hypothalamic-pituitary-thyroid axis has retained similar homeostatic mechanisms present in the rodent brain, centrally mediated by the opposing effects of NPY/AGRP and {alpha}MSH on hypophysiotropic TRH neurons in the PVN (15, 16, 18, 21). Thus, during fasting or other disorders that result in the nonthyroidal illness syndrome (43) the seemingly paradoxic fall in pro-TRH mRNA levels in the PVN in both man and experimental animals (45, 46, 47, 48), when circulating thyroid hormone levels are low, may be explained at least in part by the increased secretion of NPY/AGRP and/or the decreased secretion of {alpha}MSH to reduce thyroid thermogenesis and conserve peripheral energy stores.


    Footnotes
 
1 This work was supported by NIH Grants DK-37021 and MH-44694. Back

Received November 10, 1999.

Revised February 25, 2000.

Accepted March 22, 2000.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Schwartz MW, Baskin DG, Kaiyala KJ, Woods SC. 1999 Model for the regulation of energy balance and adiposity by the central nervous system. Am J Clin Nutr. 69:584–596.[Abstract/Free Full Text]
  2. Flier JS. 1998 What’s in a name? In search of leptin’s physiologic role. J Clin Endocrinol Metab. 83:1407–1413.[Free Full Text]
  3. Cheung CC, Clifton DK, Steiner RA. 1997 Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus. Endocrinology. 138:4489–4492.[Abstract/Free Full Text]
  4. Hakansson ML, Hulting AL, Meister B. 1996 Expression of leptin receptor mRNA in the hypothalamic arcuate nucleus–relationship with NPY neurones. NeuroReport. 7:3087–3092.[Medline]
  5. Hakansson ML, Brown H, Ghilardi N, Skoda RC, Meister B. 1998 Leptin receptor immunoreactivity in chemically defined target neurons of the hypothalamus. J Neurosci. 18:559–572.[Abstract/Free Full Text]
  6. Huang XF, Koutcherov I, Lin S, Wang HQ, Storlien L. 1996 Localization of leptin receptor mRNA expression in mouse brain. NeuroReport. 7:2635–2638.[Medline]
  7. Mercer JG, Hoggard N, Williams LM, et al. 1996 Coexpression of leptin receptor and preproneuropeptide Y mRNA in arcuate nucleus of mouse hypothalamus. J Neuroendocrinol. 8:733–5.
  8. Mercer JG, Hoggard N, Williams LM, Lawrence CB, Hannah LT, Trayhurn P. 1996 Localization of leptin receptor mRNA and the long form splice variant (Ob-Rb) in mouse hypothalamus and adjacent brain regions by in situ hybridization. FEBS Lett. 387:113–116.[CrossRef][Medline]
  9. Schwartz MW, Seeley RJ, Campfield LA, Burn P, Baskin DG. 1996 Identification of targets of leptin action in rat hypothalamus. J Clin Invest. 98:1101–1106.[Medline]
  10. Rossi M, Kim MS, Morgan DG, et al. 1998 A C-terminal fragment of agouti-related protein increases feeding and antagonizes the effect of {alpha}-melanocyte stimulating hormone in vivo. Endocrinology. 139:4428–4431.[Abstract/Free Full Text]
  11. Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD. 1997 Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature. 385:165–168.[CrossRef][Medline]
  12. Kalra SP, Sahu A, Kalra PS, Crowley WR. 1990 Hypothalamic neuropeptide Y: a circuit in the regulation of gonadotropin secretion and feeding behavior. Ann NY Acad Sci. 611:273–283.[Medline]
  13. Caballero C, Celis ME. 1993 The effect of the blockade of {alpha}-melanocyte-stimulating hormone on LH release in the rat. J Endocrinol. 137:197–202.[Abstract]
  14. Hahn TM, Breininger JF, Baskin DG, Schwartz MW. 1998 Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons. Nat Neurosci. 1:271–272.[CrossRef][Medline]
  15. Legradi G, Lechan RM. 1999 Agouti-related protein containing nerve terminals innervate thyrotropin-releasing hormone neurons in the hypothalamic paraventricular nucleus. Endocrinology. 140:3643–3652.[Abstract/Free Full Text]
  16. Legradi G, Lechan RM. 1998 The arcuate nucleus is the major source for neuropeptide Y-innervation of thyrotropin-releasing hormone neurons in the hypothalamic paraventricular nucleus. Endocrinology. 139:3262–3270.[Abstract/Free Full Text]
  17. Mizuno TM, Mobbs CV. 1999 Hypothalamic agouti-related protein messenger ribonucleic acid is inhibited by leptin and stimulated by fasting. Endocrinology. 140:814–817.[Abstract/Free Full Text]
  18. Legradi G, Emerson CH, Ahima RS, Rand WM, Flier JS, Lechan RM. 1998 Arcuate nucleus ablation prevents fasting-induced suppression of proTRH mRNA in the hypothalamic paraventricular nucleus. Neuroendocrinology. 68:89–97.[CrossRef][Medline]
  19. Mizuno TM, Kleopoulos SP, Bergen HT, Roberts JL, Priest CA, Mobbs CV. 1998 Hypothalamic pro-opiomelanocortin mRNA is reduced by fasting and in ob/ob and db/db mice, but is stimulated by leptin. Diabetes. 47:294–297.[Abstract]
  20. Schwartz MW, Seeley RJ, Woods SC, et al. 1997 Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes. 46:2119–2123.
  21. Fekete C, Légrádi G, Mihály E, et al. 2000 {alpha}-Melanocyte stimulating hormone is contained in nerve terminals innervating thyrotropin-releasing hormone- synthesizing neurons in the hypothalamic paraventricular nucleus and prevents fasting induced suppression of prothyrotropin-releasing hormone gene expression. J Neurosci. 20:1550–1558.[Abstract/Free Full Text]
  22. Mihaly E, Fekete C, Liposits Z, Stopa EG, Lechan RM. Hypophysiotropic thyrotropin-releasing hormone-synthesizing neurons of the human hypothalamus are innervated by axons containing neuropeptide Y, and agouti related protein [Abstract]. Proc of the 29th Annual Meet of the Soc for Neurosci. 1999; 1690.
  23. Elias CF, Saper CB, Maratos-Flier E, et al. 1998 Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area. J Comp Neurol. 402:442–459.[CrossRef][Medline]
  24. Liposits Z, Sherman D, Phelix C, Paull WK. 1986 A combined light and electron microscopic immunocytochemical method for the simultaneous localization of multiple tissue antigens. Tyrosine hydroxylase immunoreactive innervation of corticotropin releasing factor synthesizing neurons in the paraventricular nucleus of the rat. Histochemistry. 85:95–106.[CrossRef][Medline]
  25. Merchenthaler I, Csernus V, Csontos C, Petrusz P, Mess B. 1988 New data on the immunocytochemical localization of thyrotropin- releasing hormone in the rat central nervous system. Am J Anat. 181:359–376.[CrossRef][Medline]
  26. Dobo E, Dudas B, Kallo I, Liposits Z. 1996 Novel immunohistochemical procedures for simultaneous detection of neuropeptides in human brain. Neurobiology. 4:139.
  27. Toni R, Jackson IM, Lechan RM. 1990 Neuropeptide-Y-immunoreactive innervation of thyrotropin-releasing hormone-synthesizing neurons in the rat hypothalamic paraventricular nucleus. Endocrinology. 126:2444–2453.[Abstract]
  28. Broberger C, Johansen J, Johansson C, Schalling M, Hokfelt T. 1998 The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. Proc Natl Acad Sci USA. 95:15043–15048.[Abstract/Free Full Text]
  29. Halliday GM, Li YW, Oliver JR, et al. 1988 The distribution of neuropeptide Y-like immunoreactive neurons in the human medulla oblongata. Neuroscience. 26:179–191.[CrossRef][Medline]
  30. Hokfelt T, Lundberg JM, Lagercrantz H, et al. 1983 Occurrence of neuropeptide Y (NPY)-like immunoreactivity in catecholamine neurons in the human medulla oblongata. Neurosci Lett. 36:217–222.[CrossRef][Medline]
  31. Sawchenko PE, Swanson LW, Grzanna R, Howe PR, Bloom SR, Polak JM. 1985 Colocalization of neuropeptide Y immunoreactivity in brainstem catecholaminergic neurons that project to the paraventricular nucleus of the hypothalamus. J Comp Neurol. 241:138–153.[CrossRef][Medline]
  32. Allen YS, Adrian TE, Allen JM, et al. 1983 Neuropeptide Y distribution in the rat brain. Science. 221:877–879.[Abstract/Free Full Text]
  33. Mantyh PW, Kemp JA. 1983 The distribution of putative neurotransmitters in the lateral geniculate nucleus of the rat. Brain Res. 288:344–348.[CrossRef][Medline]
  34. Ollmann MM, Lamoreux ML, Wilson BD, Barsh GS. 1998 Interaction of agouti protein with the melanocortin 1 receptor in vitro and in vivo. Genes Dev. 12:316–330.[Abstract/Free Full Text]
  35. Ollmann MM, Wilson BD, Yang YK, et al. 1997 Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science. 278:135–138.[Abstract/Free Full Text]
  36. Brady LS, Smith MA, Gold PW, Herkenham M. 1990 Altered expression of hypothalamic neuropeptide mRNAs in food-restricted and food-deprived rats. Neuroendocrinology. 52:441–447.[Medline]
  37. Bergendahl M, Wiemann JN, Clifton DK, Huhtaniemi I, Steiner RA. 1992 Short-term starvation decreases POMC mRNA but does not alter GnRH mRNA in the brain of adult male rats. Neuroendocrinology. 56:913–920.[Medline]
  38. Wilson BD, Bagnol D, Kaelin CB, et al. 1999 Physiological and anatomical circuitry between agouti-related protein and leptin signaling. Endocrinology. 140:2387–2397.
  39. Beck B, Jhanwar-Uniyal M, Burlet A, Chapleur-Chateau M, Leibowitz SF, Burlet C. 1990 Rapid and localized alterations of neuropeptide Y in discrete hypothalamic nuclei with feeding status. Brain Res. 528:245–249.[CrossRef][Medline]
  40. Legradi G, Emerson CH, Ahima RS, Flier JS, Lechan RM. 1997 Leptin prevents fasting-induced suppression of prothyrotropin-releasing hormone messenger ribonucleic acid in neurons of the hypothalamic paraventricular nucleus. Endocrinology. 138:2569–2576.[Abstract/Free Full Text]
  41. Rondeel JM, Heide R, de Greef WJ, et al. 1992 Effect of starvation and subsequent refeeding on thyroid function and release of hypothalamic thyrotropin-releasing hormone. Neuroendocrinology. 56:348–353.
  42. van Haasteren GA, Linkels E, Klootwijk W, et al. 1995 Starvation-induced changes in the hypothalamic content of prothyrotrophin-releasing hormone (proTRH) mRNA and the hypothalamic release of proTRH-derived peptides: role of the adrenal gland. J Endocrinol. 145:143–153.[Abstract]
  43. de Groot LJ. 1999 Dangerous dogmas in medicine: the nonthyroidal illness syndrome. J Clin Endocrinol Metab. 84:151–164.[Free Full Text]
  44. Erickson JC, Ahima RS, Hollopeter G, Flier JS, Palmiter RD. 1997 Endocrine function of neuropeptide Y knockout mice. Regul Pept. 70:199–202.[CrossRef][Medline]
  45. Blake NG, Eckland DJ, Foster OJ, Lightman SL. 1991 Inhibition of hypothalamic thyrotropin-releasing hormone messenger ribonucleic acid during food deprivation. Endocrinology. 129:2714–2718.[Abstract]
  46. Shi ZX, Levy A, Lightman SL. 1993 The effect of dietary protein on thyrotropin-releasing hormone and thyrotropin gene expression. Brain Res. 606:1–4.[CrossRef][Medline]
  47. Kakucska I, Romero LI, Clark BD, et al. 1994 Suppression of thyrotropin-releasing hormone gene expression by interleukin-1-ß in the rat: implications for nonthyroidal illness. Neuroendocrinology. 59:129–137.[CrossRef][Medline]
  48. Fliers E, Guldenaar SE, Wiersinga WM, Swaab DF. 1997 Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with nonthyroidal illness. J Clin Endocrinol Metab. 82:4032–4036.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
EndocrinologyHome page
E. Sanchez, P. S. Singru, C. Fekete, and R. M. Lechan
Induction of Type 2 Iodothyronine Deiodinase in the Mediobasal Hypothalamus by Bacterial Lipopolysaccharide: Role of Corticosterone
Endocrinology, May 1, 2008; 149(5): 2484 - 2493.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Menyhert, G. Wittmann, R. M. Lechan, E. Keller, Z. Liposits, and C. Fekete
Cocaine- and Amphetamine-Regulated Transcript (CART) Is Colocalized with the Orexigenic Neuropeptide Y and Agouti-Related Protein and Absent from the Anorexigenic {alpha}-Melanocyte-Stimulating Hormone Neurons in the Infundibular Nucleus of the Human Hypothalamus
Endocrinology, September 1, 2007; 148(9): 4276 - 4281.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Voss-Andreae, J. G. Murphy, K. L. J. Ellacott, R. C. Stuart, E. A. Nillni, R. D. Cone, and W. Fan
Role of the Central Melanocortin Circuitry in Adaptive Thermogenesis of Brown Adipose Tissue
Endocrinology, April 1, 2007; 148(4): 1550 - 1560.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Alkemade, C. L. Vuijst, U. A. Unmehopa, O. Bakker, B. Vennstrom, W. M. Wiersinga, D. F. Swaab, and E. Fliers
Thyroid Hormone Receptor Expression in the Human Hypothalamus and Anterior Pituitary
J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 904 - 912.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Gavrila, J. L. Chan, L. C. Miller, K. Heist, N. Yiannakouris, and C. S. Mantzoros
Circulating Melanin-Concentrating Hormone, Agouti-Related Protein, and {alpha}-Melanocyte-Stimulating Hormone Levels in Relation to Body Composition: Alterations in Response to Food Deprivation and Recombinant Human Leptin Administration
J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 1047 - 1054.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. H. Bates, T. A. Dundon, M. Seifert, M. Carlson, E. Maratos-Flier, and M. G. Myers Jr
LRb-STAT3 Signaling Is Required for the Neuroendocrine Regulation of Energy Expenditure by Leptin
Diabetes, December 1, 2004; 53(12): 3067 - 3073.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Fekete, D. L. Marks, S. Sarkar, C. H. Emerson, W. M. Rand, R. D. Cone, and R. M. Lechan
Effect of Agouti-Related Protein in Regulation of the Hypothalamic-Pituitary-Thyroid Axis in the Melanocortin 4 Receptor Knockout Mouse
Endocrinology, November 1, 2004; 145(11): 4816 - 4821.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. Huo, H. Munzberg, E. A. Nillni, and C. Bjorbaek
Role of Signal Transducer and Activator of Transcription 3 in Regulation of Hypothalamic trh Gene Expression by Leptin
Endocrinology, May 1, 2004; 145(5): 2516 - 2523.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. F. Turi, Z. Liposits, S. M. Moenter, C. Fekete, and E. Hrabovszky
Origin of Neuropeptide Y-Containing Afferents to Gonadotropin-Releasing Hormone Neurons in Male Mice
Endocrinology, November 1, 2003; 144(11): 4967 - 4974.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. Munzberg, L. Huo, E. A. Nillni, A. N. Hollenberg, and C. Bjorbaek
Role of Signal Transducer and Activator of Transcription 3 in Regulation of Hypothalamic Proopiomelanocortin Gene Expression by Leptin
Endocrinology, May 1, 2003; 144(5): 2121 - 2131.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Sarkar and R. M. Lechan
Central Administration of Neuropeptide Y Reduces {alpha}-Melanocyte-Stimulating Hormone-Induced Cyclic Adenosine 5'-Monophosphate Response Element Binding Protein (CREB) Phosphorylation in Pro-Thyrotropin-Releasing Hormone Neurons and Increases CREB Phosphorylation in Corticotropin-Releasing Hormone Neurons in the Hypothalamic Paraventricular Nucleus
Endocrinology, January 1, 2003; 144(1): 281 - 291.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Fekete, S. Sarkar, W. M. Rand, J. W. Harney, C. H. Emerson, A. C. Bianco, and R. M. Lechan
Agouti-Related Protein (AGRP) Has a Central Inhibitory Action on the Hypothalamic-Pituitary-Thyroid (HPT) Axis; Comparisons between the Effect of AGRP and Neuropeptide Y on Energy Homeostasis and the HPT Axis
Endocrinology, October 1, 2002; 143(10): 3846 - 3853.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
T Reinehr and W Andler
Thyroid hormones before and after weight loss in obesity
Arch. Dis. Child., October 1, 2002; 87(4): 320 - 323.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Argyropoulos, T. Rankinen, D. R. Neufeld, T. Rice, M. A. Province, A. S. Leon, J. S. Skinner, J. H. Wilmore, D. C. Rao, and C. Bouchard
A Polymorphism in the Human Agouti-Related Protein Is Associated with Late-Onset Obesity
J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4198 - 4202.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. P. Goldstone, U. A. Unmehopa, S. R. Bloom, and D. F. Swaab
Hypothalamic NPY and Agouti-Related Protein Are Increased in Human Illness But Not in Prader-Willi Syndrome and Other Obese Subjects
J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 927 - 937.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. H. Koegler, K. L. Grove, A. Schiffmacher, M. S. Smith, and J. L. Cameron
Central Melanocortin Receptors Mediate Changes in Food Intake in the Rhesus Macaque
Endocrinology, June 1, 2001; 142(6): 2586 - 2592.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. Fekete, E. Mihaly, L.-G. Luo, J. Kelly, J. T. Clausen, Q. Mao, W. M. Rand, L. G. Moss, M. Kuhar, C. H. Emerson, et al.
Association of Cocaine- and Amphetamine-Regulated Transcript-Immunoreactive Elements with Thyrotropin-Releasing Hormone-Synthesizing Neurons in the Hypothalamic Paraventricular Nucleus and Its Role in the Regulation of the Hypothalamic-Pituitary-Thyroid Axis during Fasting
J. Neurosci., December 15, 2000; 20(24): 9224 - 9234.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow